As of 2026-04-22, the Intrinsic Value of Faron Pharmaceuticals Oy (FARN.L) is -65.90 GBP. This FARN.L valuation is based on the model Peter Lynch Fair Value. With the current market price of 45.40 GBP, the upside of Faron Pharmaceuticals Oy is -245.16%.
Based on its market price of 45.40 GBP and our intrinsic valuation, Faron Pharmaceuticals Oy (FARN.L) is overvalued by 245.16%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -65.90 - -65.90 | -65.90 | -245.16% |
| P/E | (29.00) - (48.77) | (27.02) | -159.5% |
| DDM - Stable | (90.44) - (253.85) | (172.14) | -479.2% |
| DDM - Multi | (54.45) - (123.44) | (76.08) | -267.6% |
| Market Cap (mil) | 81.90 |
| Beta | 0.00 |
| Outstanding shares (mil) | 1.80 |
| Enterprise Value (mil) | 92.69 |
| Market risk premium | 5.98% |
| Cost of Equity | 11.44% |
| Cost of Debt | 5.00% |
| WACC | 10.16% |